These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 35838966)

  • 1. Detection of IgG Antibodies to SARS-CoV-2 and Neutralizing Capabilities Using the Luminex
    King A; King G; Weiss C; Dunbar S; Das S
    Methods Mol Biol; 2022; 2511():257-271. PubMed ID: 35838966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative evaluation of Luminex based assays for detection of SARS-CoV-2 antibodies in a transplantation laboratory.
    Cox A; Stevens M; Kallon D; Gupta A; White E
    J Immunol Methods; 2023 Jun; 517():113472. PubMed ID: 37059296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous Measurement of IgM and IgG Antibodies to SARS-CoV-2 Spike, RBD, and Nucleocapsid Multiplexed in a Single Assay on the xMAP INTELLIFLEX DR-SE Flow Analyzer.
    Cameron A; Bohrhunter JL; Porterfield CA; Mangat R; Karasick MH; Pearson Z; Angeloni S; Pecora ND
    Microbiol Spectr; 2022 Apr; 10(2):e0250721. PubMed ID: 35389244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS COV-2- IgG antibodies in blood donors in pandemic - A game changer for policy makers.
    Mahapatra S
    Transfus Clin Biol; 2022 Feb; 29(1):11-15. PubMed ID: 34653615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of xMAP SARS-CoV-2 Multi-Antigen IgG assay in Nigeria.
    Iriemenam NC; Ige FA; Greby SM; Mpamugo A; Abubakar AG; Dawurung AB; Esiekpe MK; Thomas AN; Okoli MU; Awala SS; Ugboaja BN; Achugbu CC; Odoh I; Nwatu FD; Olaleye T; Akayi L; Akinmulero OO; Dattijo J; Onokevbagbe E; Okunoye O; Mba N; Agala NP; Uwandu M; Aniedobe M; Stafford KA; Abimiku A; Hamada Y; Swaminathan M; Okoye MI; Steinhardt LC; Audu R
    PLoS One; 2022; 17(4):e0266184. PubMed ID: 35363818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal Comparison of Automated SARS-CoV-2 Serology Assays in Assessing Virus Neutralization Capacity in COVID-19 Convalescent Sera.
    Niedrist T; Drexler C; Torreiter PP; Matejka J; Strahlhofer-Augsten M; Kral S; Riegler S; Gülly C; Zurl C; Kriegl L; Krause R; Berghold A; Steinmetz I; Schlenke P; Herrmann M
    Arch Pathol Lab Med; 2022 May; 146(5):538-546. PubMed ID: 35085385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Convalescent plasma therapy for the treatment of patients with COVID-19: Assessment of methods available for antibody detection and their correlation with neutralising antibody levels.
    Harvala H; Robb ML; Watkins N; Ijaz S; Dicks S; Patel M; Supasa P; Wanwisa D; Liu C; Mongkolsapaya J; Bown A; Bailey D; Vipond R; Grayson N; Temperton N; Gupta S; Ploeg RJ; Bolton J; Fyfe A; Gopal R; Simmonds P; Screaton G; Thompson C; Brooks T; Zambon M; Miflin G; Roberts DJ
    Transfus Med; 2021 Jun; 31(3):167-175. PubMed ID: 33333627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19 Antibody Detection and Assay Performance Using Red Cell Agglutination.
    Srivastava K; West KA; De Giorgi V; Holbrook MR; Bovin NV; Henry SM; Flegel WA
    Microbiol Spectr; 2021 Dec; 9(3):e0083021. PubMed ID: 34878316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of a Multiplex Bead Assay against Single-Target Assays for Detection of IgG Antibodies to SARS-CoV-2.
    Mitchell KF; Carlson CM; Nace D; Wakeman BS; Drobeniuc J; Niemeyer GP; Werner B; Hoffmaster AR; Satheshkumar PS; Schuh AJ; Udhayakumar V; Rogier E
    Microbiol Spectr; 2022 Jun; 10(3):e0105422. PubMed ID: 35647696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2 neutralizing capacity among blood donors without prior COVID-19 symptomatic history vs. blood donors with prior COVID-19 symptomatic history: A comparative study.
    Ravula U; Chunchu SR; Mooli S; Naik R; Sarangapati PRR
    Transfus Clin Biol; 2022 May; 29(2):107-111. PubMed ID: 35167958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Convalescent plasma for COVID-19: Donor demographic factors associated high neutralising antibody titres.
    Mehew J; Johnson R; Roberts D; Griffiths A; Harvala H
    Transfus Med; 2022 Aug; 32(4):327-337. PubMed ID: 35434868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiplex Immunoassay Approaches Using Luminex® xMAP® Technology for the Study of COVID-19 Disease.
    Das S; Dunbar S
    Adv Exp Med Biol; 2023; 1412():479-489. PubMed ID: 37378784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of a multiplexed coronavirus antigen array for detection of SARS-CoV-2 specific IgG in COVID-19 convalescent plasma.
    Huey L; Andersen G; Merkel PA; Morrison TE; McCarthy M; DomBourian MG; Annen K; Dawson ED; Rowlen KL; Knight V
    J Immunol Methods; 2021 Oct; 497():113104. PubMed ID: 34303688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of a multiplex flow immunoassay for detection of IgG antibodies against SARS-CoV-2 in dried blood spots.
    Turgeon CT; Sanders KA; Rinaldo P; Granger D; Hilgart H; Matern D; Theel ES
    PLoS One; 2021; 16(5):e0252621. PubMed ID: 34048503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative Performance of Five Commercially Available Serologic Assays To Detect Antibodies to SARS-CoV-2 and Identify Individuals with High Neutralizing Titers.
    Patel EU; Bloch EM; Clarke W; Hsieh YH; Boon D; Eby Y; Fernandez RE; Baker OR; Keruly M; Kirby CS; Klock E; Littlefield K; Miller J; Schmidt HA; Sullivan P; Piwowar-Manning E; Shrestha R; Redd AD; Rothman RE; Sullivan D; Shoham S; Casadevall A; Quinn TC; Pekosz A; Tobian AAR; Laeyendecker O
    J Clin Microbiol; 2021 Jan; 59(2):. PubMed ID: 33139419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of Three Quantitative Anti-SARS-CoV-2 Antibody Immunoassays.
    Chapuy-Regaud S; Miédougé M; Abravanel F; Da Silva I; Porcheron M; Fillaux J; Diméglio C; Izopet J
    Microbiol Spectr; 2021 Dec; 9(3):e0137621. PubMed ID: 34937195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production of anti-SARS-CoV-2 hyperimmune globulin from convalescent plasma.
    Vandeberg P; Cruz M; Diez JM; Merritt WK; Santos B; Trukawinski S; Wellhouse A; Jose M; Willis T
    Transfusion; 2021 Jun; 61(6):1705-1709. PubMed ID: 33715160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-SARS-CoV-2 Immunoglobulin Isotypes, and Neutralization Activity Against Viral Variants, According to BNT162b2-Vaccination and Infection History.
    Tarkowski M; de Jager W; Schiuma M; Covizzi A; Lai A; Gabrieli A; Corbellino M; Bergna A; Ventura CD; Galli M; Riva A; Antinori S
    Front Immunol; 2021; 12():793191. PubMed ID: 34975897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SARS-CoV-2 Convalescent Sera Binding and Neutralizing Antibody Concentrations Compared with COVID-19 Vaccine Efficacy Estimates against Symptomatic Infection.
    Schuh AJ; Satheshkumar PS; Dietz S; Bull-Otterson L; Charles M; Edens C; Jones JM; Bajema KL; Clarke KEN; McDonald LC; Patel S; Cuffe K; Thornburg NJ; Schiffer J; Chun K; Bastidas M; Fernando M; Petropoulos CJ; Wrin T; Cai S; Adcock D; Sesok-Pizzini D; Letovsky S; Fry AM; Hall AJ; Gundlapalli AV
    Microbiol Spectr; 2022 Aug; 10(4):e0124722. PubMed ID: 35856710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutralization of SARS-CoV-2 with IgG from COVID-19-convalescent plasma.
    Maeda K; Higashi-Kuwata N; Kinoshita N; Kutsuna S; Tsuchiya K; Hattori SI; Matsuda K; Takamatsu Y; Gatanaga H; Oka S; Sugiyama H; Ohmagari N; Mitsuya H
    Sci Rep; 2021 Mar; 11(1):5563. PubMed ID: 33692457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.